Page last updated: 2024-08-23

raloxifene hydrochloride and homocysteine

raloxifene hydrochloride has been researched along with homocysteine in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (12.50)	18.2507
2000's	11 (68.75)	29.6817
2010's	3 (18.75)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
de Valk-de Roo, GW; Jakobs, C; Kenemans, P; Mijatovic, V; Netelenbos, C; van der Mooren, MJ	1
Kenemans, P; Mijatovic, V; Netelenbos, JC; Stehouwer, CD; van der Mooren, MJ	1
Anderson, PW; Cox, DA; Dean, RA; Paul, S; Tracy, RP; Walsh, BW; Wild, RA	1
De Leo, V; la Marca, A; Lanzetta, D; Morgante, G; Petraglia, F; Setacci, C	1
Mijatovic, V; van der Mooren, MJ	1
Kenemans, P; Mijatovic, V; Neele, SJ; Netelenbos, JC; Smolders, RG; van Baal, WM; van der Mooren, MJ; Vogelvang, TE	1
Christodoulakos, G; Coutoukos, J; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D	1
Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F	1
Kenemans, P; Mijatovic, V; Teerlink, T; van der Mooren, MJ; Vogelvang, TE	1
Duschek, EJ; Neele, SJ; Netelenbos, C; Rosing, J; Thomassen, MC	1
Akan, P; Dogan, E; Gol, M; Karas, C; Posaci, C; Saygili, U	1
Boscaro, M; Camilletti, A; Francucci, CM	1
Bayram, M; Kabakci, N; Kalender, H; Kisa, U; Ozer, G; Ozkan, Y	1
Iwamoto, J	1
Inokuchi, N; Kishikawa, H; Mori, H; Okada, Y; Sugimoto, H; Tanaka, Y	1
Ma, KM; Mok, CC; Wong, CK; Ying, SK	1

Reviews

4 review(s) available for raloxifene hydrochloride and homocysteine

Article	Year
Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1999, Volume: 13, Issue:2 Topics: Animals; Cardiovascular Diseases; Cardiovascular System; Endothelium, Vascular; Estrogen Antagonists; Estrogens; Female; Hemostasis; Homocysteine; Hormone Replacement Therapy; Humans; Lipoprotein(a); Muscle, Smooth, Vascular; Piperidines; Progestins; Raloxifene Hydrochloride; Risk Factors	1999
Homocysteine in postmenopausal women and the importance of hormone replacement therapy. Clinical chemistry and laboratory medicine, 2001, Volume: 39, Issue:8 Topics: Cardiovascular Diseases; Clinical Trials as Topic; Female; Homocysteine; Hormone Replacement Therapy; Humans; Postmenopause; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Time Factors	2001
Raloxifene and cardiovascular health: its relationship to lipid and glucose metabolism, hemostatic and inflammation factors and cardiovascular function in postmenopausal women. Current pharmaceutical design, 2005, Volume: 11, Issue:32 Topics: Aged; Binding Sites; Cardiovascular System; Endothelium, Vascular; Female; Glucose; Hemostasis; Homocysteine; Humans; Inflammation; Lipid Metabolism; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Ventricular Function, Left	2005
[Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis]. Clinical calcium, 2010, Volume: 20, Issue:3 Topics: Biomarkers; Bone Density Conservation Agents; Diphosphonates; Female; Fractures, Spontaneous; Homocysteine; Humans; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Estrogen Receptor Modulators; Spinal Fractures	2010

Trials

11 trial(s) available for raloxifene hydrochloride and homocysteine

Article	Year
Randomized, double-blind, placebo-controlled study of the effects of raloxifene and conjugated equine estrogen on plasma homocysteine levels in healthy postmenopausal women. Fertility and sterility, 1998, Volume: 70, Issue:6 Topics: Administration, Oral; Animals; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Fasting; Female; Homocysteine; Horses; Humans; Hysterectomy; Middle Aged; Piperidines; Placebos; Postmenopause; Raloxifene Hydrochloride; Receptors, Estrogen; Reference Values	1998
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. The Journal of clinical endocrinology and metabolism, 2000, Volume: 85, Issue:1 Topics: Aged; C-Reactive Protein; Double-Blind Method; Estrogen Replacement Therapy; Female; Fibrinogen; Homocysteine; Humans; Lipids; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Risk Factors	2000
Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women. American journal of obstetrics and gynecology, 2001, Volume: 184, Issue:3 Topics: Aged; Calcium Carbonate; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromatography, High Pressure Liquid; Endometrium; Female; Homocysteine; Humans; Lipids; Middle Aged; Patient Compliance; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides; Ultrasonography	2001
A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine. Maturitas, 2002, Feb-26, Volume: 41, Issue:2 Topics: Cardiovascular Diseases; Double-Blind Method; Estrogens, Conjugated (USP); Female; Homocysteine; Hormone Replacement Therapy; Humans; Lipoprotein(a); Medroxyprogesterone Acetate; Middle Aged; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2002
Effect of raloxifene, estrogen, and hormone replacement therapy on serum homocysteine levels in postmenopausal women. Fertility and sterility, 2003, Volume: 79, Issue:2 Topics: Biomarkers; Estrogen Replacement Therapy; Estrogens; Female; Homocysteine; Humans; Middle Aged; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators	2003
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene. Human reproduction (Oxford, England), 2004, Volume: 19, Issue:2 Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12	2004
HMR 3339, a novel selective estrogen receptor modulator, reduces total cholesterol, low-density lipoprotein cholesterol, and homocysteine in healthy postmenopausal women. Fertility and sterility, 2004, Volume: 82, Issue:6 Topics: Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Female; Homocysteine; Humans; Middle Aged; Osmolar Concentration; Postmenopause; Raloxifene Hydrochloride; Reference Values; Selective Estrogen Receptor Modulators	2004
Effect of raloxifene on activated protein C (APC) resistance in postmenopausal women and on APC resistance and homocysteine levels in elderly men: two randomized placebo-controlled studies. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:8 Topics: Activated Protein C Resistance; Aged; Double-Blind Method; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Factor V; Female; Homocysteine; Humans; Male; Medroxyprogesterone Acetate; Middle Aged; Placebos; Postmenopause; Raloxifene Hydrochloride	2004
Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels. Maturitas, 2006, Feb-20, Volume: 53, Issue:3 Topics: Adult; Aged; C-Reactive Protein; Drug Combinations; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Homocysteine; Humans; Medroxyprogesterone Acetate; Megestrol; Middle Aged; Norpregnadienes; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome	2006
Effects of raloxifene on lipid and bone metabolism in postmenopausal women with type 2 diabetes. Journal of bone and mineral metabolism, 2013, Volume: 31, Issue:1 Topics: Aged; Alkaline Phosphatase; Biomarkers; Blood Glucose; Bone and Bones; Bone Density Conservation Agents; Cholesterol, LDL; Collagen Type I; Diabetes Mellitus, Type 2; Female; Homocysteine; Humans; Male; Middle Aged; Peptides; Postmenopause; Raloxifene Hydrochloride	2013
Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: subgroup analysis of a double-blind randomized controlled trial. Lupus, 2013, Volume: 22, Issue:14 Topics: Biomarkers; Bone Density; Bone Density Conservation Agents; C-Reactive Protein; Double-Blind Method; Estrogen Antagonists; Female; Follow-Up Studies; Glucocorticoids; Homocysteine; Humans; Lumbar Vertebrae; Lupus Erythematosus, Systemic; Middle Aged; Postmenopause; Prednisolone; Raloxifene Hydrochloride; Severity of Illness Index; Treatment Outcome	2013

Other Studies

1 other study(ies) available for raloxifene hydrochloride and homocysteine

Article	Year
The effects of raloxifene and tibolone on homocysteine and vascular histopathological changes. Clinical and experimental medicine, 2007, Volume: 7, Issue:4 Topics: Animals; Atherosclerosis; Carotid Arteries; Estrogen Replacement Therapy; Female; Folic Acid; Homocysteine; Norpregnenes; Raloxifene Hydrochloride; Rats; Rats, Wistar; Vitamin B 12	2007